Safety of linezolid in patients with baseline thrombocytopenia.

1. Chow KM, Hui AC, Szeto CC. Neurotoxicity induced by b-lactam antibiotics: from bench to bedside. Eur J Clin Microbiol Infect Dis 2005; 24: 649–53. 2. Yahav D, Paul M, Fraser A et al. Efficacy and safety of cefepime: a systematic review and meta-analysis. Lancet infect Dis 2007; 7: 338–48. 3. Dixit S, Kurle P, Buyan-Dent L et al. Status epilepticus associated with cefepime. Neurology 2000; 54: 2153–5. 4. Lam S, Gomolin IH. Cefepime neurotoxicity: case report pharmacokinetic considerations literature review. Pharmacotherapy 2006; 26: 1169–74. 5. Chow KM, Szeto CC, Hui AC et al. Mechanisms of antibiotic neurotoxicity in renal failure. Int J Antimicrob Agents 2004; 23: 213–7. 6. Malone RS, Fish DN, Abraham E et al. Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients. Antimicrob Agents Chemother 2001; 45: 3148–55. 7. Allaouchiche B, Breilh D, Jaumain H et al. Pharmacokinetics of cefepime during continuous venovenous hemodiafiltration. Antimicrob Agents Chemother 1997; 41: 2424–7. 8. Isla A, Gascon AR, Maynar J et al. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients. Clin Ther 2005; 27: 599–608.